tiprankstipranks
Lexaria Bioscience (LEXX)
NASDAQ:LEXX
US Market
Holding LEXX?
Track your performance easily

Lexaria Bioscience (LEXX) Income Statement

178 Followers

Lexaria Bioscience Income Statement

Last quarter (Q ), Lexaria Bioscience's total revenue was $84.00K, an increase of 8.10% from the same quarter last year. In Q, Lexaria Bioscience's net income was $-1.78M. See Lexaria Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Aug 23Aug 22Aug 21Aug 20Aug 19
Total Revenue
$ 275.37K$ 226.21K$ 255.40K$ 722.74K$ 384.54K$ 222.61K
Cost of Revenue
$ 4.82K$ 31.50K$ 71.84K$ 175.35K$ 99.38K$ 22.89K
Gross Profit
$ 270.55K$ 194.71K$ 183.56K$ 547.39K$ 215.41K$ 199.72K
Operating Expense
$ 4.99M$ 6.73M$ 6.80M$ 6.23M$ 4.36M$ 4.26M
Operating Income
$ -4.72M$ -6.53M$ -6.62M$ -5.69M$ -4.15M$ -4.06M
Net Non Operating Interest Income Expense
$ 50.51K$ 43.19K----
Other Income Expense
$ 301.03K$ -221.69K$ 764.61K$ 1.52M$ -96.33K$ -98.62K
Pretax Income
$ -4.97M$ -6.71M$ -7.38M$ -4.16M$ -4.15M$ -4.16M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -4.96M$ -6.66M$ -7.50M$ -4.03M$ -3.93M$ -4.10M
Basic EPS
$ -0.49$ -1.01$ -1.24-$ -45.00$ -45.00
Diluted EPS
$ -0.49$ -1.01$ -1.24-$ -45.00$ -45.00
Basic Average Shares
$ 41.79M$ 6.61M$ 5.89M-$ 92.44K$ 86.43K
Diluted Average Shares
$ 41.79M$ 6.61M$ 5.89M-$ 92.44K$ 86.43K
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 5.00M$ 6.76M$ 6.87M$ -6.41M$ -4.46M$ -4.28M
Net Income From Continuing And Discontinued Operation
$ -4.96M$ -6.66M$ -7.50M$ -4.03M$ -3.93M$ -4.10M
Normalized Income
$ -4.58M$ -4.93M$ -5.43M$ -4.58M$ -2.99M$ -2.97M
Interest Expense
------
EBIT
$ -4.97M$ -6.71M$ -7.38M$ -4.16M$ -4.15M$ -4.16M
EBITDA
$ -4.84M$ -6.57M$ -7.28M$ -4.02M$ -4.00M$ -4.10M
Currency in USD

Lexaria Bioscience Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis